Showing 2711-2720 of 4012 results for "".
- Prognostic Biomarkers in Endometrial Cancer: The Role of Emerging Gene Signatureshttps://reachmd.com/news/prognostic-biomarkers-in-endometrial-cancer-the-role-of-emerging-gene-signatures/2474846/Endometrial cancer's varied and often unpredictable clinical profile leads to differing patient outcomes. This variability underscores the urgent need for new biomarkers to better forecast prognosis and guide personalized treatment. Uncovering new molecular markers
- Experimental Drug and Its Impact on Slowing Rare ALS Progressionhttps://reachmd.com/news/experimental-drug-and-its-impact-on-slowing-rare-als-progression/2474812/Recent clinical trials examining an innovative drug for a rare ALS form present hopeful evidence in slowing the swift progression typical of this devastating condition. The experimental therapy shows potential in decelerating rare ALS progress, opening
- Single-Stage Revision and Prosthetic Joint Infection Management in Hip Arthroplastyhttps://reachmd.com/news/single-stage-revision-and-prosthetic-joint-infection-management-in-hip-arthroplasty/2474784/Overview and Significance Recent advancements in surgical technique and infectious disease management have brought single-stage revision to the forefront in the treatment of prosthetic joint infections (PJIs). This progressi
- Combination Therapy and Outcomes in Childhood B-Cell Acute Lymphoblastic Leukemiahttps://reachmd.com/news/combination-therapy-and-outcomes-in-childhood-b-cell-acute-lymphoblastic-leukemia/2474731/Recent innovations in pediatric oncology reveal a dual-drug therapy developed by Cambridge researchers, representing a significant leap forward by reducing chemotherapy reliance while improving outcomes, notably in older pediatric B-cell acute lymphoblastic leukemia patient
- Genetic Modulation of Cortical Development: The Role of HARE5 Enhancerhttps://reachmd.com/news/genetic-modulation-of-cortical-development-the-role-of-hare5-enhancer/2474727/The identification of the HARE5 enhancer is a pivotal leap forward in comprehending brain development. This human-specific genetic element significantly impacts neural progenitor proliferation, contributing to cortical expansion. This discovery not only elucidates
- Adolescent Mental Health: The Link Between Cyberbullying and PTSDhttps://reachmd.com/news/adolescent-mental-health-the-link-between-cyberbullying-and-ptsd/2474684/In the evolving digital age, where adolescents connect, learn, and socialize through screens, a darker force has quietly embedded itself into their daily lives—cyberbullying. No longer a fringe issue, this form of digital harassment has emerged as a powerful trigger
- skinbetter science® Launches Even Intensive Skin Tone Correcting Serumhttps://reachmd.com/news/skinbetter-science-launches-even-intensive-skin-tone-correcting-serum/2475366/skinbetter science® has announced the launch Even Intensive Skin Tone Correcting Serum, an advanced discoloration treatment formulated to address persistent dark marks, uneven tone, and skin texture irregularities. According to
- FANCX Gene Identified as Driver of Severe Fanconi Anemiahttps://reachmd.com/news/genetic-insights-into-fanconi-anemia-the-role-of-a-new-gene/2474613/A newly identified genetic mutation in FANCX—previously known as FAAP100—has been confirmed as a causative factor in particularly severe forms of Fanconi anemia (FA), a rare inherited
- AI-Driven Viral Mutation Prediction: Enhancing Future-Proof COVID Vaccine Strategieshttps://reachmd.com/news/ai-driven-viral-mutation-prediction-enhancing-future-proof-covid-vaccine-strategies/2474632/Artificial intelligence is transforming vaccine development by enabling researchers to forecast SARS-CoV-2 mutations and guide the design of next-generation COVID vaccines. By simulating potential escape mutations with synthetic spike proteins, scientists can refin
- Ansa Biotechnologies Pushes Past Synthetic DNA Length Limits With 50 kb Early Access Programhttps://reachmd.com/news/ansa-biotechnologies-pushes-past-synthetic-dna-length-limits-with-50-kb-early-access-program/2474571/At this year’s Global Synthetic Biology Conference in San Jose, Ansa Biotechnologies unveiled a bold leap forward in synthetic DNA capabilities: the ability to deliver complex DNA sequences up to 50 kilobases (kb) in length, a major departure